SCM
CVS icon

Shelton Capital Management’s CVS Health CVS Stock Holding History

Shelton Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Sell
156,347
-168,989
-52% -$15.1M 0.3% 76
2026
Q1 		$23.4M Sell
325,336
-118,561
-27% -$9.13M 0.51% 39
2025
Q4 		$35.2M Buy
443,897
+268,816
+154% +$21.2M 0.7% 27
2025
Q3 		$13.2M Buy
175,081
+8,905
+5% +$610K 0.28% 85
2025
Q2 		$11.5M Buy
166,176
+94,433
+132% +$6.19M 0.26% 97
2025
Q1 		$4.86M Buy
71,743
+15,202
+27% +$910K 0.12% 156
2024
Q4 		$2.54M Hold
56,541
– – 0.06% 207
2024
Q3 		$3.56M Sell
56,541
-361
-0.6% -$21.1K 0.09% 190
2024
Q2 		$3.36M Hold
56,902
– – 0.09% 200
2024
Q1 		$4.54M Buy
56,902
+500
+0.9% +$38.2K 0.13% 174
2023
Q4 		$4.45M Sell
56,402
-5,310
-9% -$378K 0.14% 166
2023
Q3 		$4.31M Sell
61,712
-199
-0.3% -$14.1K 0.16% 158
2023
Q2 		$4.28M Sell
61,911
-38,858
-39% -$2.76M 0.15% 143
2023
Q1 		$7.49M Buy
100,769
+69,769
+225% +$5.85M 0.31% 86
2022
Q4 		$2.89M Sell
31,000
-8,705
-22% -$840K 0.3% 113
2022
Q3 		$3.79M Buy
39,705
+30,872
+350% +$3.06M 0.18% 133
2022
Q2 		$818K Hold
8,833
– – 0.04% 271
2022
Q1 		$894K Sell
8,833
-100
-1% -$10.5K 0.03% 283
2021
Q4 		$922K Sell
8,933
-8,775
-50% -$811K 0.03% 282
2021
Q3 		$1.5M Sell
17,708
-14,100
-44% -$1.18M 0.06% 245
2021
Q2 		$2.65M Sell
31,808
-81,341
-72% -$6.66M 0.1% 206
2021
Q1 		$8.51M Buy
113,149
+11,326
+11% +$825K 0.3% 73
2020
Q4 		$6.96M Buy
101,823
+33,674
+49% +$2.19M 0.31% 67
2020
Q3 		$3.98M Buy
68,149
+31,550
+86% +$1.96M 0.16% 140
2020
Q2 		$2.38M Buy
36,599
+6,903
+23% +$435K 0.13% 153
2020
Q1 		$1.76M Buy
29,696
+20,512
+223% +$1.37M 0.13% 150
2019
Q4 		$682K Sell
9,184
-2,612
-22% -$183K 0.04% 282
2019
Q3 		$744K Sell
11,796
-600
-5% -$35.6K 0.04% 261
2019
Q2 		$675K Buy
12,396
+11,749
+1,816% +$633K 0.04% 280
2019
Q1 		$12K Sell
647
-10,464
-94% -$646K 0.05% 341
2018
Q4 		$728K Buy
11,111
+2,165
+24% +$162K 0.05% 248
2018
Q3 		$704K Sell
8,946
-1,938
-18% -$139K 0.04% 280
2018
Q2 		$700K Buy
10,884
+638
+6% +$42K 0.04% 281
2018
Q1 		$637K Sell
10,246
-8,800
-46% -$631K 0.04% 306
2017
Q4 		$1.38M Sell
19,046
-33,814
-64% -$2.46M 0.09% 193
2017
Q3 		$4.3M Buy
52,860
+8,574
+19% +$678K 0.29% 78
2017
Q2 		$3.56M Buy
44,286
+35,428
+400% +$2.8M 0.25% 90
2017
Q1 		$695K Sell
8,858
-2,436
-22% -$194K 0.05% 282
2016
Q4 		$891K Sell
11,294
-1,700
-13% -$138K 0.07% 253
2016
Q3 		$1.16M Sell
12,994
-2,010
-13% -$190K 0.1% 193
2016
Q2 		$1.44M Buy
15,004
+10
+0.1% +$997 0.13% 151
2016
Q1 		$1.55M Buy
14,994
+500
+3% +$48.6K 0.14% 137
2015
Q4 		$1.42M Buy
14,494
+1,350
+10% +$132K 0.14% 140
2015
Q3 		$1.27M Buy
13,144
+31
+0.2% +$3.26K 0.14% 143
2015
Q2 		$1.38M Sell
13,113
-621
-5% -$63.4K 0.14% 141
2015
Q1 		$1.42M Buy
13,734
+600
+5% +$60.7K 0.15% 140
2014
Q4 		$1.26M Sell
13,134
-3,831
-23% -$338K 0.15% 134
2014
Q3 		$1.35M Buy
16,965
+1,300
+8% +$102K 0.18% 109
2014
Q2 		$1.18M Buy
15,665
+5,400
+53% +$408K 0.16% 124
2014
Q1 		$768K Sell
10,265
-900
-8% -$63.6K 0.11% 184
2013
Q4 		$799K Buy
11,165
+200
+2% +$12.8K 0.12% 173
2013
Q3 		$622K Buy
10,965
+1,303
+13% +$77.6K 0.1% 213
2013
Q2 		$552K Buy
+9,662
New +$560K 0.1% 222

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Shelton Capital Management's CVS Position: Q2 2026 in Review

Shelton Capital Management reduced its CVS Health (CVS) stake by 52% in Q2 2026, selling an estimated $15.1M and leaving 156,347 shares worth $16.2M. The position accounts for 0.3% of the portfolio, ranked #76.

Shelton Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.2M in Q4 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Shelton Capital Management held 156,347 shares of CVS Health worth $16.2M as of Q2 2026.
  • Shelton Capital Management sold 168,989 CVS Health shares in Q2 2026, an estimated $15.1M.
  • CVS Health made up 0.3% of Shelton Capital Management's portfolio in Q2 2026, its #76 holding.
  • Shelton Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Shelton Capital Management's CVS Health position peaked at $35.2M in Q4 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.